This content is 9 years old. Content may be out of date.

The Millennium Development Goals (MDG) agenda post 2015: drugs, cure or curse?

29 Jan 2015
WWARN Published Date

8th European Congress on Tropical Medicine and International Health, 2013 (ECTMIH-2013)

Tuesday, September 10, 2013 at the Congress Hall, Tivoli Congress Center, Copenhagen, Denmark

13:30-15:00 Session 4.8.1 

The worldwide pharmaceutical market has changed significantly over the last few decades. Less developed countries are trying to find solutions to improve their access to quality medicines and diagnostics. It could be argued that improved collaboration amongst the key stakeholders involved in international health, together with stronger regulatory control and supervision of drug quality, would help many countries improve their access. 

Dr. Paul Newton, WWARN’s Head of Antimalarial Quality Group, will be part of a panel presenting together with colleagues from QUAMED, a program of the Institute of Tropical Medicine in Antwerp, Belgium on the latest results and learning on antimalarial drug quality. Paul will present the latest data on the epidemiology of poor quality antimalarials and highlight the potential public health impact. He will also consider the issue of the low level national and international responses to this problem, and discuss the potential interventions that might improve the quality of antimalarials that patients take.

Details of the panel themes are summarised below, we hope to see you there. Contact us for further information

Chairperson: Karel Gyselinck, Belgian Technical Cooperation 

Moderator: Dr. Raffaella Ravinetto, Institute of Tropical Medicine, Belgium

Presentations:

Antimalarials quality, what do we know?, Dr. Paul Netwon, Head of the Antimalarial Quality Group at the WorldWide Antimalarial Network (WWARN), Centre for Tropical Medicine, University of Oxford, UK

Poor medicines for negelected diseases: the case of leishmaniasis, Dr. Thomas Dorlo, Utrecht University, The Netherlands

In-Vitro diagnostics: (inter)national regulations and quality in resource limited settings, Jan Jacobs, Institute of Tropical Medicine, Belgium

Sharing the information and the resources in an independent network: A new strategy to improve the access to quality medicines, Benedetta Schiavetti, Research and education, QUAMED pharmacist, Institute of Tropical Medicine, Belgium

Roundtable discussion: Current and future actions: round table with all the panellists and questions from the audience